STOCK TITAN

[Form 4] HeartBeam, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank reported a Form 4 showing a sale of 17,647 shares of Common Stock and a grant of 23,333 Restricted Stock Units (RSUs) on 09/30/2025. The RSUs were issued under the company’s 2022 Equity Incentive Plan and vest in two equal tranches: one half on the three‑month anniversary of the vesting commencement date (July 1, 2025 start) and the remainder on the six‑month anniversary. The filing notes RSUs do not expire and are either vested or canceled. The report was signed by the reporting person on 10/03/2025.

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank ha riportato un modulo 4 che mostra la vendita di 17.647 azioni ordinarie e una concessione di 23.333 unità azionarie soggette a restrizioni (RSU) in data 30/09/2025. Le RSU sono state emesse ai sensi del 2022 Equity Incentive Plan della società e vestono in due tranche uguali: metà entro il terzo mese dall'inizio della vesting (1 luglio 2025 come data di inizio) e il restante entro il sesto mese. La nota di deposito indica che le RSU non scadono e sono o acquisite o cancellate. Il rapporto è stato firmato dalla persona indicante il resoconto in data 03/10/2025.

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank reportó un Formulario 4 que muestra la venta de 17,647 acciones ordinarias y una concesión de 23,333 Unidades de Stock Restringidas (RSU) en 30/09/2025. Las RSU fueron emitidas bajo el Plan de Incentivos de Capital 2022 de la compañía y se consolidan en dos tramos iguales: la mitad en el tercer mes a partir de la fecha de inicio de la consolidación (1 de julio de 2025 como inicio) y la restante en el sexto mes. La presentación señala que las RSU no expiran y se consolidan o se cancelan. El informe fue firmado por la persona informante el 03/10/2025.

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank09/30/202517,647 주의 보통주 매매와 23,333 Restricted Stock Units (RSUs) 부여를 포함하는 Form 4를 보고했다. RSU는 회사의 2022 Equity Incentive Plan에 따라 발행되었으며 두 개의 동등한 트랜치로 vest 된다: 시작일(vesting 시작일 2025년 7월 1일 시작)으로부터의 3개월 차 시점과 6개월 차 시점에 각각 절반씩 vest되고, 남은 절반은 6개월 차에 vest 된다. 제출 문서는 RSU가 만료되지 않으며 취득되거나 취소된다고 명시한다. 보고자는 2025년 10월 3일에 보고서를 서명했다.

HeartBeam, Inc. (BEAT) le directeur financier Tim Cruickshank a déclaré un formulaire 4 montrant la vente de 17 647 actions ordinaires et une attribution de 23 333 unités d’actions restreintes (RSU) le 30/09/2025. Les RSU ont été émises en vertu du Plan d’incitation à l’actionnariat 2022 de l’entreprise et vestent en deux tranches égales: la moitié au troisième mois à compter de la date de début de l’acquisition (1er juillet 2025 comme début) et le reste au sixième mois. Le dépôt note que les RSU n’expirent pas et sont soit acquises, soit annulées. Le rapport a été signé par la personne déclarante le 03/10/2025.

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank berichtete ein Form 4, das den Verkauf von 17.647 Stammaktien und eine Zuteilung von 23.333 Restricted Stock Units (RSUs) am 30.09.2025 zeigt. Die RSUs wurden gemäß dem 2022 Equity Incentive Plan des Unternehmens ausgegeben und vesten in zwei gleichen Tranchen: Die Hälfte am dreimonatigen Jubiläum des Vesting-Anfangs (1. Juli 2025 Start) und der Rest am sechsmonatigen Jubiläum. Der Bericht nennt, dass RSUs weder verfallen noch storniert werden. Der Bericht wurde von der meldenden Person am 03.10.2025 unterzeichnet.

HeartBeam, Inc. (BEAT) ذكـر المدير المالي Tim Cruickshank نموذج فورم 4 يظهر بيع 17,647 سهم عادي ومنحة 23,333 وحدة أسهم مقيدة (RSUs) في 30/09/2025. تم إصدار RSUs بموجب خطة الحوافز للأسهم 2022 للشركة وتكتسب وحدة vest وفق دفعتين متساويتين: نصفها في الذكرى الثلاثة لبدء الاستحقاق (1 يوليو 2025 كبداية) والباقي في الذكرى six أشهر. يذكر البيان أن RSUs لا تنتهي صلاحيتها وهي إما مكتسبة أو مُلغاة. وقع التقرير من قبل الشخص المبلغ في 03/10/2025.

HeartBeam, Inc. (BEAT) 首席财务官 Tim Cruickshank 报告了一份 Form 4,显示在 2025/09/30 出售了 17,647 股普通股并授予 23,333 受限股票单位(RSUs)。RSUs 根据公司的 2022 年股权激励计划 发出,分两期等额 vest:第一部分在 vesting 开始日期的三个月纪念日时归属(2025 年 7 月 1 日 开始)其余部分在六个月纪念日时归属。文件指出 RSU 不到期且要么已归属要么被取消。该报告由申报人于 2025/10/03 签署。

Positive
  • 23,333 RSUs granted under the 2022 Equity Incentive Plan, aligning executive compensation with shareholders
  • RSU vesting schedule is time‑based with clear dates (three‑ and six‑month anniversaries), providing transparency
Negative
  • 17,647 shares disposed by the CFO, representing an insider sale disclosed on Form 4
  • Immediate insider sale and near‑term vesting could increase free float in the short term

Insights

TL;DR: CFO sold 17,647 shares and received 23,333 RSUs vesting over 3–6 months.

The Form 4 documents two distinct actions: a disposal of 17,647 common shares and a grant of 23,333 RSUs under the 2022 Equity Incentive Plan. The RSUs vest in two equal installments tied to a vesting commencement date of July 1, 2025, with no listed expiration.

This filing is material to shareholders because it records immediate insider selling and a near‑term equity compensation schedule for a senior officer; both items are factual disclosures required by Section 16 and may affect short‑term share count and insider ownership disclosure.

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank ha riportato un modulo 4 che mostra la vendita di 17.647 azioni ordinarie e una concessione di 23.333 unità azionarie soggette a restrizioni (RSU) in data 30/09/2025. Le RSU sono state emesse ai sensi del 2022 Equity Incentive Plan della società e vestono in due tranche uguali: metà entro il terzo mese dall'inizio della vesting (1 luglio 2025 come data di inizio) e il restante entro il sesto mese. La nota di deposito indica che le RSU non scadono e sono o acquisite o cancellate. Il rapporto è stato firmato dalla persona indicante il resoconto in data 03/10/2025.

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank reportó un Formulario 4 que muestra la venta de 17,647 acciones ordinarias y una concesión de 23,333 Unidades de Stock Restringidas (RSU) en 30/09/2025. Las RSU fueron emitidas bajo el Plan de Incentivos de Capital 2022 de la compañía y se consolidan en dos tramos iguales: la mitad en el tercer mes a partir de la fecha de inicio de la consolidación (1 de julio de 2025 como inicio) y la restante en el sexto mes. La presentación señala que las RSU no expiran y se consolidan o se cancelan. El informe fue firmado por la persona informante el 03/10/2025.

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank09/30/202517,647 주의 보통주 매매와 23,333 Restricted Stock Units (RSUs) 부여를 포함하는 Form 4를 보고했다. RSU는 회사의 2022 Equity Incentive Plan에 따라 발행되었으며 두 개의 동등한 트랜치로 vest 된다: 시작일(vesting 시작일 2025년 7월 1일 시작)으로부터의 3개월 차 시점과 6개월 차 시점에 각각 절반씩 vest되고, 남은 절반은 6개월 차에 vest 된다. 제출 문서는 RSU가 만료되지 않으며 취득되거나 취소된다고 명시한다. 보고자는 2025년 10월 3일에 보고서를 서명했다.

HeartBeam, Inc. (BEAT) le directeur financier Tim Cruickshank a déclaré un formulaire 4 montrant la vente de 17 647 actions ordinaires et une attribution de 23 333 unités d’actions restreintes (RSU) le 30/09/2025. Les RSU ont été émises en vertu du Plan d’incitation à l’actionnariat 2022 de l’entreprise et vestent en deux tranches égales: la moitié au troisième mois à compter de la date de début de l’acquisition (1er juillet 2025 comme début) et le reste au sixième mois. Le dépôt note que les RSU n’expirent pas et sont soit acquises, soit annulées. Le rapport a été signé par la personne déclarante le 03/10/2025.

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank berichtete ein Form 4, das den Verkauf von 17.647 Stammaktien und eine Zuteilung von 23.333 Restricted Stock Units (RSUs) am 30.09.2025 zeigt. Die RSUs wurden gemäß dem 2022 Equity Incentive Plan des Unternehmens ausgegeben und vesten in zwei gleichen Tranchen: Die Hälfte am dreimonatigen Jubiläum des Vesting-Anfangs (1. Juli 2025 Start) und der Rest am sechsmonatigen Jubiläum. Der Bericht nennt, dass RSUs weder verfallen noch storniert werden. Der Bericht wurde von der meldenden Person am 03.10.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Cruickshank Tim

(Last) (First) (Middle)
2118 WALSH AVE
SUITE 210

(Street)
SANTA CLARA CA 95050

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 17,647 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Award $0 (1) (2) Common Stock 23,333 23,333 D
Explanation of Responses:
1. Granted Restricted Stock Units (RSU's) on September 30, 2025, one half of the total number of Shares subject to the Special RSU shall vest on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remaining Shares subject to the Special RSU shall vest on the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.
2. RSUs do not expire, they either vest or are canceled prior to vesting date
Remarks:
/s/ Tim Cruickshank 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HeartBeam CFO Tim Cruickshank report on Form 4 (BEAT)?

The Form 4 reports a disposal of 17,647 common shares and a grant of 23,333 RSUs on 09/30/2025.

What is the vesting schedule for the RSUs reported in the BEAT Form 4?

The RSUs vest in two equal tranches: one half on the three‑month anniversary and the remainder on the six‑month anniversary of the vesting commencement date (July 1, 2025).

Under which plan were the RSUs issued?

The RSUs were issued under the company’s 2022 Equity Incentive Plan.

Do the RSUs reported for BEAT expire?

The filing states that the RSUs do not expire; they either vest or are canceled prior to vesting.

When was the Form 4 signed?

The Form 4 was signed by Tim Cruickshank on 10/03/2025.
Heartbeam Inc

NASDAQ:BEAT

BEAT Rankings

BEAT Latest News

BEAT Latest SEC Filings

BEAT Stock Data

60.39M
26.15M
23.8%
10.48%
0.36%
Health Information Services
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA